| Labette County Medical Center | |
|
613 Maple Street Chetopa KS 67336 | |
| (620) 236-7300 | |
| (620) 236-7930 |
| Full Name | Labette County Medical Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 613 Maple Street, Chetopa, Kansas |
| Authorized Official Name and Position | Thomas L Macaronas (VP FINANCE) |
| Authorized Official Contact | 6208205251 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Labette County Medical Center Po Box 736 Parsons KS 67357-0736 Ph: (620) 820-5889 | Labette County Medical Center 613 Maple Street Chetopa KS 67336 Ph: (620) 236-7300 |
| NPI Number | 1720639644 |
|---|---|
| Provider Enumeration Date | 09/23/2019 |
| Last Update Date | 09/23/2019 |
| Medicare PECOS PAC ID | 5496664369 |
|---|---|
| Medicare Enrollment ID | O20191030003372 |
News Archive
Using information about the unique mating practices of the male malaria mosquito ― which, unlike any other insect, inserts a plug to seal its sperm inside the female ― scientists are zeroing in on a birth-control drug for Anopheles mosquitoes, deadly carriers of the disease that threatens 3 billion people, has infected more than 215 million and kills 655,000 annually.
"Up to three million people in Afghanistan are facing hunger, malnutrition and disease after a severe drought wiped out their crops and extreme winter weather risks cutting off their access to vital food aid, a group of aid agencies warned Friday," Reuters reports.
Researchers at the Ontario Institute for Cancer Research and University Health Network in Toronto, along with researchers at the Eastern Virginia Medical School, have created protein signatures that accurately diagnose prostate cancer and can distinguish between patients with aggressive versus non-aggressive disease using a simple urine sample.
Australian drug development company CBio Limited today announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA).
Immune reactions are usually a good thing-;the body's way of eliminating harmful bacteria and other pathogens. But people also rely on molecular "brakes," or checkpoints, to keep immune systems from attacking their own cells and organs and causing so-called autoimmune disease.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720639644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Using information about the unique mating practices of the male malaria mosquito ― which, unlike any other insect, inserts a plug to seal its sperm inside the female ― scientists are zeroing in on a birth-control drug for Anopheles mosquitoes, deadly carriers of the disease that threatens 3 billion people, has infected more than 215 million and kills 655,000 annually.
"Up to three million people in Afghanistan are facing hunger, malnutrition and disease after a severe drought wiped out their crops and extreme winter weather risks cutting off their access to vital food aid, a group of aid agencies warned Friday," Reuters reports.
Researchers at the Ontario Institute for Cancer Research and University Health Network in Toronto, along with researchers at the Eastern Virginia Medical School, have created protein signatures that accurately diagnose prostate cancer and can distinguish between patients with aggressive versus non-aggressive disease using a simple urine sample.
Australian drug development company CBio Limited today announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA).
Immune reactions are usually a good thing-;the body's way of eliminating harmful bacteria and other pathogens. But people also rely on molecular "brakes," or checkpoints, to keep immune systems from attacking their own cells and organs and causing so-called autoimmune disease.
› Verified 7 days ago
Onh Medical Group, Chetopa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 429 Maple St, Chetopa, KS 67336 Phone: 620-979-9464 Fax: 620-979-9466 | |
Chetopa Community Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 429 Maple Street, Box 106, Chetopa, KS 67336 Phone: 620-236-7351 Fax: 620-236-7976 | |
Chetopa Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 507 Maple St, Chetopa, KS 67336 Phone: 620-236-7322 Fax: 620-236-7323 | |
Chetopa Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 507 Maple St, Chetopa, KS 67336 Phone: 620-236-7322 Fax: 620-236-7323 |